Managing R&D Daiichi Sankyo Style
This article was originally published in PharmAsia News
Executive Summary
At an R&D briefing in Japan last month, Daiichi Sankyo unsurprisingly declared that shorter development timelines, improved research productivity and reduced costs were among its main objectives. But open innovation and external collaborations were also described as important to its quest for innovation.